DE19907305A1 - Products with three or more discrete and optically-distinguishable phases containing active substances, dyes and preservatives - Google Patents
Products with three or more discrete and optically-distinguishable phases containing active substances, dyes and preservativesInfo
- Publication number
- DE19907305A1 DE19907305A1 DE19907305A DE19907305A DE19907305A1 DE 19907305 A1 DE19907305 A1 DE 19907305A1 DE 19907305 A DE19907305 A DE 19907305A DE 19907305 A DE19907305 A DE 19907305A DE 19907305 A1 DE19907305 A1 DE 19907305A1
- Authority
- DE
- Germany
- Prior art keywords
- phase
- water
- phases
- soluble
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000975 dye Substances 0.000 title claims abstract description 7
- 239000003755 preservative agent Substances 0.000 title claims abstract 5
- 239000013543 active substance Substances 0.000 title description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003921 oil Substances 0.000 claims abstract description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract 6
- 239000002904 solvent Substances 0.000 claims abstract 4
- 238000004519 manufacturing process Methods 0.000 claims abstract 3
- 239000004480 active ingredient Substances 0.000 claims description 6
- 230000005484 gravity Effects 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims 2
- 238000004321 preservation Methods 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 3
- 239000012071 phase Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- QYYMDNHUJFIDDQ-UHFFFAOYSA-N 5-chloro-2-methyl-1,2-thiazol-3-one;2-methyl-1,2-thiazol-3-one Chemical compound CN1SC=CC1=O.CN1SC(Cl)=CC1=O QYYMDNHUJFIDDQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 229920001774 Perfluoroether Polymers 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- -1 isooctyl Chemical group 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- UJMWVICAENGCRF-UHFFFAOYSA-N oxygen difluoride Chemical compound FOF UJMWVICAENGCRF-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229950011087 perflunafene Drugs 0.000 description 1
- UWEYRJFJVCLAGH-IJWZVTFUSA-N perfluorodecalin Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)[C@@]2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[C@@]21F UWEYRJFJVCLAGH-IJWZVTFUSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B61/00—Dyes of natural origin prepared from natural sources, e.g. vegetable sources
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Lösliche Wirkstoffe sind durch ihre Struktur bestimmt entweder hy drophil oder lipophil. Bisher ist es daher üblich und ausreichend, Produkte mit 2 Phasen, einer Fettphase und einer Wasserphase, auszustatten, um jeden löslichen Wirkstoff in einem Produkt kombi niert darreichen zu können. Dabei ist es unabhängig, ob die beiden Phasen diskret übereinandergeschichtet und damit organoleptisch unterscheidbar bestehen oder durch Emulgatoren miteinander ver mischt sind. Um größeren Spielraum bei der Kombination von Wirk stoffen zu haben, hat man bereits 3-Phasen-Emulsionsprodukte ent wickelt. Das Vorhandensein von 3 Phasen ist in dieser Produktform für den Anwender optisch nicht wahrnehmbar.Soluble drugs are determined by their structure either hy drophil or lipophilic. So far it is common and sufficient, Products with 2 phases, a fat phase and a water phase, to equip any soluble active ingredient in a product to be able to give it. It does not matter if the two Phases discretely stacked and thus organoleptic distinguishable or ver together by emulsifiers are mixed. To give greater latitude in the combination of Wirk already have 3-phase emulsion products ent wraps. The presence of 3 phases is in this product form optically imperceptible to the user.
Wenn man 3 oder mehr Phasen in einem Produkt vereinigen könnte
und dieses für den Anwender optisch nachvollziehbar machen wür
de, hätte man folgende Vorteile in einem Produkt:
If you could combine 3 or more phases in one product and make it visually comprehensible for the user, you would have the following advantages in one product:
- 1. Attraktivere optische Produkterscheinung1. More attractive optical product appearance
- 2. Kombination nicht kombinierbarer Stoffe in verschiedenen Phasen2. Combination of non-combinable substances in different phases
- 3. Depoteffekte3. Custodian effects
- 4. Schutzeffekte4. Protective effects
- 5. Andere Wirk- und Penetrations-Kinetik5. Other activity and penetration kinetics
Da alle Rohstoffe zunächst nur in lipophil und hydrophil unterteilbar sind, schien das Ziel unserer Erfindung nicht erreichbar. Erst das Angebot neuartiger Rohstoffe, die bei der Formulierungsarbeit kon ventioneller Produkte Probleme machen und Inkompartibilitäten mit üblichen Rohstoffen zeigen, wies den Weg zur Lösung der Aufgabe.Since all raw materials are initially subdividable only in lipophilic and hydrophilic are, the goal of our invention seemed unattainable. Only that Offer of novel raw materials that are used in the formulation work of conventional products cause problems and incompatibilities show usual resources, pointed the way to the solution of the problem.
So sind es dann unter anderen
Fluorierte Verbindungen (Fluorether, Perfluordekalin etc.)
Silikonderivate (Cyclomethicon, Dimethicon etc.)
die sich von einer Fettphase bestehend aus
Wachsestern und/oder
Paraffinölen und/oder
Pflanzenölen etc.
abtrennen, auf Grund des spezifischen Gewichtes absetzen und mit
einer Wasserphase zusammen 3 und mehr Phasen bilden, die sich in
einem Produkt vereinigt anbieten lassen. Diese lassen sich durch
Ausnutzung des Nernstschen Gesetzes und der damit verschiedenar
tigen Löslichkeit von Farbstoffen in den einzelnen Phasen gut un
terscheidbar anfärben. In den verschiedenen Phasen lassen sich die
dort bevorzugt lösliche Wirkstoffe integrieren:
Wasserphase: wasserlösliche Wirkstoffe
Fettphase: fettlösliche Wirkstoffe
Perfluorierte Phase: Gase wie Sauerstoff, Stickstoff
Silikonderivatphase: SchutzkomponentenSo it is among others
Fluorinated compounds (fluoroether, perfluorodecalin, etc.)
Silicone derivatives (cyclomethicone, dimethicone etc.)
consisting of a fatty phase consisting of
Wax star and / or
Paraffin oils and / or
Separate vegetable oils, etc., settle on the basis of specific gravity and form together with a water phase 3 and more phases that can be combined in one product offered. By using Nernst's law and the resulting solubility of dyes in the individual phases, these can be stained well and distinctly. In the different phases, it is possible to integrate the active substances which are preferably soluble there:
Water phase: water-soluble active ingredients
Fat phase: fat-soluble active ingredients
Perfluorinated phase: gases such as oxygen, nitrogen
Silicone derivative phase: protective components
Verhältnis der Phasen 1 : 2 : 3 : 4 wie 1 : 1 : 1 : 0,2 Ratio of phases 1: 2: 3: 4 as 1: 1: 1: 0.2
Verhältnis der Phasen 1 : 2 : 3 : 4 wie 2 : 1 : 2 : 0.5Ratio of phases 1: 2: 3: 4 as 2: 1: 2: 0.5
Claims (1)
Phase 1 aus konventionellen Ölen
Phase 2 aus mit Phase 1 und 4 nicht kompatiblen lipophilen Komponenten mit einem spezifischen Gewicht kleiner 1
Phase 3 aus Wasser und hydrophilen Lösungsmitteln wie z. B. Propylenglykol, Glycerin etc.
Phase 4 aus mit Phase 1 und 2 nicht kompatiblen lipophilen Komponenten, mit einem spezifischen Gewicht größer 1
besteht, in die jeweils Wirkstoffe, Farben und Konservierung inte griert sind.Protection is requested for product formulas, their production and their application, those of the general formula
Phase 1 from conventional oils
Phase 2 of lipophilic components not compatible with phase 1 and 4 and having a specific gravity less than 1
Phase 3 of water and hydrophilic solvents such. As propylene glycol, glycerol, etc.
Phase 4 of lipophilic components incompatible with Phase 1 and 2, with a specific gravity greater than 1
consisting of active ingredients, colors and preservatives.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19907305A DE19907305A1 (en) | 1999-02-22 | 1999-02-22 | Products with three or more discrete and optically-distinguishable phases containing active substances, dyes and preservatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19907305A DE19907305A1 (en) | 1999-02-22 | 1999-02-22 | Products with three or more discrete and optically-distinguishable phases containing active substances, dyes and preservatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE19907305A1 true DE19907305A1 (en) | 2000-08-24 |
Family
ID=7898260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19907305A Withdrawn DE19907305A1 (en) | 1999-02-22 | 1999-02-22 | Products with three or more discrete and optically-distinguishable phases containing active substances, dyes and preservatives |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE19907305A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005053636A2 (en) * | 2003-12-08 | 2005-06-16 | Coty B.V. | Cosmetic and dermatological oxygen carrier system |
FR2912656A1 (en) * | 2007-02-15 | 2008-08-22 | Dermaconcept Jmc Sarl | Pharmaceutical composition of oil-in-oil emulsion, useful to manufacture product to treat vaginal dryness, comprises mixture of glycerin, paraffin gel and/or their derivatives, perfluorinated oils, gellfied lipids and polysaccharides |
-
1999
- 1999-02-22 DE DE19907305A patent/DE19907305A1/en not_active Withdrawn
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005053636A2 (en) * | 2003-12-08 | 2005-06-16 | Coty B.V. | Cosmetic and dermatological oxygen carrier system |
WO2005053636A3 (en) * | 2003-12-08 | 2005-07-28 | Coty Bv | Cosmetic and dermatological oxygen carrier system |
JP2007513194A (en) * | 2003-12-08 | 2007-05-24 | コティ ビー.ヴィ. | Cosmetic and dermatological oxygen carrier systems |
CN1893916B (en) * | 2003-12-08 | 2010-05-26 | 科蒂股份有限公司 | Cosmetic and dermatologic oxygen carrier system |
JP4726801B2 (en) * | 2003-12-08 | 2011-07-20 | コティ ビー.ヴィ. | Cosmetic and dermatological oxygen carrier systems |
US8252297B2 (en) | 2003-12-08 | 2012-08-28 | Coty B.V. | Cosmetic and dermatologic oxygen carrier system |
FR2912656A1 (en) * | 2007-02-15 | 2008-08-22 | Dermaconcept Jmc Sarl | Pharmaceutical composition of oil-in-oil emulsion, useful to manufacture product to treat vaginal dryness, comprises mixture of glycerin, paraffin gel and/or their derivatives, perfluorinated oils, gellfied lipids and polysaccharides |
WO2008129153A1 (en) * | 2007-02-15 | 2008-10-30 | Dermaconcept Jmc | Oil-in-oil emulsion-type pharmaceutical composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0907345B1 (en) | Dual phase skin care compositions | |
DE4100490C1 (en) | ||
DE69201504T2 (en) | Cosmetic composition in the form of a triple emulsion. | |
DE69904011T2 (en) | Nanoemulsion based on sugar fatty acid esters and fatty alcohol ethers and their uses in cosmetics, dermatology and / or ophthalmology | |
EP2732805B1 (en) | Dual phase product | |
DE19924277A1 (en) | Preparations of emulsion type W / O with increased water content containing medium polar lipids and silicone emulsifiers and optionally cationic polymers | |
DE4227779B4 (en) | Three-phase lotion intended for use on the body, in pharmacy or in cosmetics | |
JPH05262620A (en) | Cosmetic emulsion consisting essentially of silicone oil | |
EP2814451A2 (en) | Stable water-in-oil emulsions with spreadable oils | |
BG107875A (en) | Skin oils consisting of oil-soluble constituents | |
EP0258558B2 (en) | Cosmetic product, particularly a skin hydratation product | |
EP1559395A3 (en) | Microemulsion | |
DE602005005082T3 (en) | FILLING AGENT BASED ON A MIXTURE OF MONOESTERN AND DIESTER OF BUTYLENE GLYCOL | |
DE19907305A1 (en) | Products with three or more discrete and optically-distinguishable phases containing active substances, dyes and preservatives | |
EP2174641A1 (en) | Oil body mixtures containing derivatives of the isosorbid | |
DE102008013804A1 (en) | Foundation with UV filter combination | |
DE19804376A1 (en) | Lipid mixtures and their use | |
JP2006241113A (en) | Oil-in-water type emulsified composition and cosmetic | |
EP3962434A1 (en) | Cosmetic o/w emulsion with scleroglucan and iron oxide pigments | |
DE102009060148A1 (en) | Cosmetic oil/water-emulsion, useful to obtain consistent skin texture after applying the emulsion on the skin, comprises pigment including inorganic white-, color- and/or multicolored pigments, and a pearlescent pigment | |
DE10116497B4 (en) | Liquid for lip care or lip coloring | |
DE29717947U1 (en) | Lip balm | |
DE20318886U1 (en) | Skin care product containing vitamin C. | |
WO2013120825A2 (en) | Stable water-in-oil emulsions with improved sensory properties | |
DE1922233C2 (en) | Cosmetic ointment, cream or paste, processes for their preparation and their use against the formation of wrinkles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8130 | Withdrawal |